Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
The Oncologist|October 12, 2020
To Transplant or Not to Transplant During the SARS-CoV-2 Pandemic? That Is the QuestionDario Marino, Silvia Finotto, Umberto Basso, et al.
British Journal of Haematology|March 16, 2004
Computer-based drug management in a bone marrow transplant unit: a suitable tool for multiple prescriptions even in critical conditionsMauro Krampera, Francesca Venturini, Fabio Benedetti, et al.
In Vivo (Athens, Greece)|September 1, 2019
Aggressive Merkel Cell Carcinoma After Janus Kinase Inhibitor Ruxolitinib for Polycythemia VeraMarco Rastrelli, Beatrice Ferrazzi, Saveria Tropea, et al.
American Journal of Hematology|June 22, 2012
Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemiaGianluigi Reda, Francesco Maura, Giuseppe Gritti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 26, 2026
PET-guided early identification of CAR-T candidates in diffuse large b-cell lymphoma: a multidisciplinary expert consensusLuca Guerra, Domenico Albano, Piera Angelillo, et al.
Blood|November 8, 2007
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemiaCarlo Visco, Marco Ruggeri, Maria Laura Evangelista, et al.
Hematological Oncology|February 25, 2022
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statementS Ferrero, Massimo Gentile, Luca Laurenti, et al.
Hematological Oncology|March 5, 2022
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statementPier Luigi Zinzani, Maurizio Martelli, S Ferrero, et al.
Annals of Hematology|March 23, 2016
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcomeGiuseppe Carli, Carlo Visco, Erika Falisi, et al.
Healthcare (Basel, Switzerland)|September 23, 2022
Tackling Mantle Cell Lymphoma in EuropeDenis Horgan, Jan Walewski, Igor Aurer, et al.
Pageof 19